0001213900-24-070066 | 20-F | XBRL Viewer

Financial Instruments (Details) $ in Thousands	12 Months Ended
Financial Instruments (Details) $ in Thousands	Dec. 31, 2023 USD ($)
Financial Instruments (Details) [Line Items]
Cash and cash equivalents amount (in Dollars)	$ 3,522

Taxes on Income (Tables)

12 Months Ended

Dec. 31, 2023

Taxes on Income [Abstract]

Schedule of Taxes on Income Included in Profit or Loss

Taxes on income included in profit or loss:

	Year ended December 31,
	2023			2022*			2021*
	USD in thousands

Current taxes		210			131			197
Deferred taxes		(39	)		(1,039	)		65
Tax previous years		-			132			-
		171			(776	)		262

Comparative figures including the discontinued operation results.

Schedule of Reconciliation Between the Tax Expense, Assuming that all the Income and Expenses, Gains and Loss

The reconciliation between the tax expense, assuming that all the income and expenses, gains and losses in profit or loss were taxed at the statutory tax rate and the taxes on income recorded in profit or loss, is as follows:

Comparative figures including the discontinued operation results.

	Year ended December 31,
	2023			2022			2021
	USD in thousands

Loss before taxes on income		(84,435	)		(80,739	)*		(13,153	)*

Statutory tax rate		23	%		23	%		23	%

Tax computed at the statutory tax rate		(19,420	)		(18,570	)		(3,025	)

Increase (decrease) in taxes on income resulting from the following factors:
Different tax rate applicable to foreign subsidiary		(2	)		(225	)		1
Utilization of carryforward losses for which no deferred taxes were computed in the past		(98	)		-			(32	)
Other losses and temporary differences for which no deferred taxes were computed		19,026			17,699			3,433
Tax previous years		-			132			-
Other, net		665			225			93

Taxes on income		171			(739	)		470

Document And Entity Information - shares	12 Months Ended
Document And Entity Information - shares	Dec. 31, 2023	Aug. 13, 2024
Document Information Line Items
Entity Registrant Name	HUB Cyber Security Ltd.
Trading Symbol	HUBCZ
Document Type	20-F
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		30,459,736
Amendment Flag	false
Entity Central Index Key	0001905660
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	Dec. 31, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	FY
Entity Emerging Growth Company	true
Entity Shell Company	false
Entity Ex Transition Period	false
ICFR Auditor Attestation Flag	false
Document Registration Statement	false
Document Annual Report	true
Document Transition Report	false
Document Shell Company Report	false
Entity File Number	001-41634
Entity Incorporation, State or Country Code	L3
Entity Address, Address Line One	2 Kaplan St
Entity Address, City or Town	Tel Aviv
Entity Address, Country	IL
Entity Address, Postal Zip Code	6473403
Title of 12(b) Security	Warrants to purchase ordinary shares
Security Exchange Name	NASDAQ
Entity Interactive Data Current	Yes
Document Financial Statement Error Correction [Flag]	false
Document Accounting Standard	International Financial Reporting Standards
Auditor Location	Israel
Auditor Name	Kost, Forer, Gabbay & Kasierer
Auditor Firm ID	1281
Business Contact
Document Information Line Items
Entity Address, Address Line One	2 Kaplan St
Entity Address, City or Town	Tel Aviv
Entity Address, Country	IL
Entity Address, Postal Zip Code	6473403
Contact Personnel Name	Noah Hershcoviz
Local Phone Number	3-791-3200
City Area Code	+972

Commitments, Guarantees, Charges and Contingent Liabilities (Details) $ / shares in Units, ₪ in Millions							1 Months Ended			12 Months Ended
	Nov. 06, 2023 USD ($)	Aug. 17, 2023 $ / shares	Jan. 30, 2023 ILS (₪)	Oct. 20, 2022 USD ($)	Oct. 20, 2022 ILS (₪)	Mar. 27, 2022	Mar. 31, 2023 USD ($) $ / shares	Dec. 31, 2022 USD ($) $ / shares	Jul. 31, 2021	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2023 ILS (₪) shares	Mar. 31, 2024 $ / shares
Commitments, Guarantees, Charges and Contingent Liabilities (Details) [Line Items]
Pledge charge amounts								$ 1,575,000		$ 1,788,000
Aggregate amount										1,839,000
Bank guarantees amount										1,839,000
Percentage of ordinary price						35.00%
Total damages										70,000,000,000	₪ 229
Reduced claimed amount (in New Shekels) \| ₪					₪ 229,440
Damage claim amount				$ 1,480,000,000	₪ 5,440
Loss Contingency damages value increased amount (in New Shekels) \| ₪			₪ 64
Failed to repay amount										2,500,000,000
Debt paid	$ 71,615
Cumulative amount										$ 350
Percentage of committed to pay fee amount									5.00%
Warrants to purchase shares percentage									5.00%
Purchase warrants (in Shares) \| shares										4,076,923	4,076,923
Marketing budget										$ 280
Non-refundable fee percentage										5.00%	5.00%
Cash payments										$ 4,200
Additionally total amount							$ 2,200,000,000
Converted price per share (in Dollars per share) \| $ / shares		$ 2					$ 10			$ 1.5
Purchase of ordinary shares value							$ 20,000,000,000
Exercise price (in Dollars per share) \| $ / shares								$ 4.81				$ 0.9
Warrant exercisable period								4 years
Total service amount										$ 140

Share-Based Payment (Details) - Schedule of Total Equity-Based Compensation Expense - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Schedule of Total Equity-Based Compensation Expense [Abstract]
Cost of revenues	$ 35	$ 206
Research and development expenses	3,010	603	3,122
Sales and marketing expenses	211	1,504	2,775
General and administrative expenses	$ 3,859	$ 8,203

Trade Receivables, Net (Details) - Schedule of Trade Receivables, Net - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Schedule of Trade Receivables Net [Abstract]
Account receivable	$ 10,051	$ 23,317
Checks collectible	27	405
Allowance for doubtful debt	(1,113)	(685)
Trade receivables, net	$ 9,867	$ 24,057

Leases (Details) - Schedule of Right-of-Use Assets, Net - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Leases (Details) - Schedule of Right-of-Use Assets, Net [Line Items]

Beginning balance

$ 2,518

$ 537

Additions during the year:

Terminated lease

(3,041)

Classification

Adjustments arising from indexation

Other

Adjustments arising from translating financial statements from functional currency to presentation currency and indexation

(49)

(413)

^[1]

Ending balance

$ 4,032

$ 2,518

[1]	The deferred taxes are computed at a tax rate of 23%.

Share-Based Payment (Tables)

12 Months Ended

Dec. 31, 2023

Share-Based Payment [Abstract]

Schedule of Total Equity-Based Compensation Expense

The total equity-based compensation expense related to all of the Company’s equity-based awards recognized for the years ended December 31, 2023, 2022 and 2021, was comprised as follows:

	Year ended December 31,
	2023		2022		2021

Cost of revenues		35		206		-
Research and development expenses		3,010		603		3,122
Sales and marketing expenses		211		1,504		2,775
General and administrative expenses		3,859		8,203		-

Total share-based payment		7,115		10,516		5,897

Long-Term Liabilities (Details) - Schedule of Other Long Term Liabilities - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of Other Long Term Liabilities [Abstract]
Balance less current maturities liabilities for government grants	$ 147	$ 887

Share-Based Payment (Details) - Schedule of Number of Share Options and the Weighted Average Exercise Prices - $ / shares

12 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Schedule of Number of Share Options and the Weighted Average Exercise Prices [Abstract]

Number of options, Share options outstanding at beginning of year

844,148

1,139,102

Number of options, Share options granted during the year

1,697,743

^[1]

29,650

Number of options, Share options exercised during the year

145,874

161,187

Number of options, Share options forfeited during the year

9,553

144,686

Number of options, Share options expired during the year

445,384

18,731

Number of options, Share options outstanding at end of year

371,575

844,148

Weighted average exercise price, Share options outstanding at end of year

$ 10.01

$ 15.94

Number of options, Share options exercisable at end of year

359,688

781,073

[1]	This includes shares granted with performance obligations which were not fulfilled as of December 31, 2023.

Accounting Policies, by Policy (Policies)

12 Months Ended

Dec. 31, 2023

Accounting Policies [Abstract]

The operating cycle

The operating cycle:

The Company’s operating cycle is one year.

Net Employee Defined Benefit Liabilities (Details) - Schedule of Amount, Timing and Uncertainty of Future Cash Flows $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($)
The change as a result of:
1% salary increase	$ (28)
1% salary decrease	360
The change as a result of:
1% decrease in discount rate	$ (49)

Share-Based Payment (Details) - Schedule of Status of RSUs - shares

12 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Schedule of Status of RSUs [Abstract]

Outstanding at beginning of year

457,137

Granted

1,697,743

^[1]

29,650

Vested

278,580

Forfeited and cancelled

260,605

Outstanding at end of year

1,615,695

457,137

[1]	This includes shares granted with performance obligations which were not fulfilled as of December 31, 2023.

Balances and Transactions with Interested and Related Parties (Details) - Schedule of Balances with Interested and Related Parties - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Balances with interested and related parties [Member]
Balances and Transactions with Interested and Related Parties (Details) - Schedule of Balances with Interested and Related Parties [Line Items]
Loan	$ 66
Transactions with interested and related parties [Member]
Balances and Transactions with Interested and Related Parties (Details) - Schedule of Balances with Interested and Related Parties [Line Items]
Highest balance of current debts during the year	$ 66	$ 0

Long-Term Liabilities (Tables)

12 Months Ended

Dec. 31, 2023

Other Long Term Liabilities [Abstract]

Schedule of Other Long Term Liabilities

Composition of other long-term liabilities:

	Effective interest rate		Balance		Balance less current maturities
	%		USD in thousands
Liabilities for government grants		11.5		412		147

	Effective interest rate		Balance		Balance less current maturities
	%		USD in thousands
Liabilities for government grants		11.5		1,289		887

Schedule of Government Grants

Government grants:

	December 31,
	2023			2022
	USD in thousands
Balance as of January 1,		1,289			961
Grants received during the year		-			77
Liability revaluation		(877	)		251
Balance as of December 31,		412			1,289

Schedule of Lease Liabilities and Other Long Term Liabilities

The maturity profile of lease liabilities and other long-term liabilities:

	First year		Second year		Third year		Fourth year		Fifth year		Sixth year and onwards		Total
	USD in thousands
Lease liabilities		382		382		382		382		-		-		1,528
Liabilities for government grants		265		30		21		19		18		59		412
Total		647		412		403		401		18		59		1,940

Goodwill and Intangible Assets, Net (Details) - Schedule of the Goodwill and the Intangible Assets $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($)
Goodwill and Intangible Assets, Net (Details) - Schedule of the Goodwill and the Intangible Assets [Line Items]
ALD Software
Dstorm

Additional Information to Profit or Loss Items

12 Months Ended

Dec. 31, 2023

Additional Information to Profit or Loss Items [Abstract]

ADDITIONAL INFORMATION TO PROFIT OR LOSS ITEMS

NOTE 24:-

ADDITIONAL INFORMATION TO PROFIT OR LOSS ITEMS

		Year ended December 31,
		2023			2022			2021
		USD in thousands

a.	Cost of revenue:

	Salaries and related expenses		28,098			29,972			11,506
	Subcontractors and consultants		8,359			12,980			8,658
	Depreciation, amortization and impairment		4,757			1,659			372
	Material		-			461			3,701
	Impairment expenses		-			438			-
	Other		693			401			474
			41,907			45,911			24,711

b.	Research and development expenses:

	Salaries and related expenses		6,879			5,201			5,468
	Other		298			406			328

			7,177			5,607			5,796
	Less – government grants		(1,291	)		(33	)		-
			5,886			5,574			5,796

c.	Sales and marketing expenses:

	Salaries and related expenses		4,239			7,972			1,910
	Advertising and public relations		236			306			37
	Depreciation, amortization and impairment		6,026			12,688			727
	Other		193			708			9
			10,694			21,674			2,683

d.	General and administrative expenses:

	Salaries and related expenses		8,409			16,089			4,844
	Depreciation and amortization		1,463			1,680			884
	Office Maintenance		1,392			1,410			303
	Consulting		16,716			16,627			1,149
	Legal expenses		2,713			2,157			411
	Impairment expenses		10,643			14,618			-
	Audit and accounting		773			1,418			249
	Insurance		1,622			26			(45	)
	Board fees		1,168			396			131
	Other		4,273			2,850			1,473
			49,172			57,271			9,313

		Year ended December 31,
		2023			2022		2021
		USD in thousands
e.	Other expenses, net:

	Governmental grants income		(1,159	)		-		-
	ELOC		1,570
	RNER listing expenses		12,312			-		-
			12,723			-		-

f.	Finance income and expenses:
	Finance income:

	Gain from exchange rate differences		271			19		-
	Interest income		213			450		5
			484			469		5
	Finance expenses:
	Loss from exchange rate differences		-			-		105
	Bank fees		109			145		105
	Changes in fair value of financial instruments		247			-		-
	Interest expenses		6,838			1,239		86
			7,194			1,384		296

Equity (Details) - Schedule of Issued and Outstanding Share Capital $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($) shares
Schedule of Issued and Outstanding Share Capital [Abstract]
Balance \| $	$ 8,879
Issuance of shares \| shares	2,848
Exercise of options and warrants \| shares	126
Balance \| $	$ 11,853

Trade Receivables, Net (Details) - Schedule of Credit Risk Exposure of the Company’s Trade Receivables $ in Thousands	Dec. 31, 2023 USD ($)
Trade Receivables, Net (Details) - Schedule of Credit Risk Exposure of the Company’s Trade Receivables [Line Items]
Allowance for doubtful accounts
Past Due Trade Receivables 30 days [Member]
Trade Receivables, Net (Details) - Schedule of Credit Risk Exposure of the Company’s Trade Receivables [Line Items]
Allowance for doubtful accounts
Past Due Trade Receivables 31-60 days [Member]
Trade Receivables, Net (Details) - Schedule of Credit Risk Exposure of the Company’s Trade Receivables [Line Items]
Allowance for doubtful accounts
Past Due Trade Receivables 60-90 days [Member]
Trade Receivables, Net (Details) - Schedule of Credit Risk Exposure of the Company’s Trade Receivables [Line Items]
Allowance for doubtful accounts
Past Due Trade Receivables 90-120 days [Member]
Trade Receivables, Net (Details) - Schedule of Credit Risk Exposure of the Company’s Trade Receivables [Line Items]
Allowance for doubtful accounts
Past Due Trade Receivables More than 120 days [Member]
Trade Receivables, Net (Details) - Schedule of Credit Risk Exposure of the Company’s Trade Receivables [Line Items]
Allowance for doubtful accounts	$ 1,113

Goodwill and Intangible Assets, Net (Details) - Schedule of Composition and Movement - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets, Net (Details) - Schedule of Composition and Movement [Line Items]
Adjustments arising from translating financial statements from functional currency to presentation currency

Financial Instruments (Details) - Schedule of Other Financial Liabilities - USD ($)
$ in Thousands

Dec. 31, 2023

Dec. 31, 2022

Schedule of Other Financial Liabilities [Abstract]

Short-term loans

^[1]

$ 11,878

$ 13,432

Convertible loans

14,449

Other accounts payable

32,427

25,322

Liabilities for government grants

$ 412

$ 1,289

[1]	The interest rate is Prime (Bank of Israel intrabank plus 1.5%) + 0.7%-4.85%.

Financials Liabilities (Details) - Schedule of Recurring Basis and Indicates the Fair Value Hierarchy of the Valuation Inputs $ in Thousands	Dec. 31, 2023 USD ($)
Financials Liabilities (Details) - Schedule of Recurring Basis and Indicates the Fair Value Hierarchy of the Valuation Inputs [Line Items]
Conversion component of convertible loans

Additional Information to Profit or Loss Items (Details) - Schedule of Additional Information to Profit or Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Additional Information to Profit or Loss Items (Details) - Schedule of Additional Information to Profit or Loss [Line Items]
Total cost of sales and services		$ 45,911
Total Research and development expenses	5,886	5,574
Total Sales and marketing expenses	10,694	21,674	2,683
Total General and administrative expenses	49,172	57,271
e. Other expenses, net:
Total Other expenses, net	$ 12,723

Share-Based Payment (Details) ₪ in Thousands, $ in Thousands	1 Months Ended		12 Months Ended
	Feb. 27, 2023 shares	Jun. 21, 2021 shares	Dec. 31, 2023 USD ($) shares	Dec. 31, 2023 ILS (₪) shares
Share-Based Payment (Details) [Line Items]
Share options (in Shares)	128,238	1,781,085	1,068,651	1,068,651
Fair value option grant			$ 2,826	₪ 10,378

Financials Liabilities (Details) - Schedule of Conversion Component of Convertible Loans	12 Months Ended
	Dec. 31, 2023
Financials Liabilities (Details) - Schedule of Conversion Component of Convertible Loans [Line Items]
Expected term (years)	4 years 4 months 6 days
IRR	20.63%

Balances and Transactions with Interested and Related Parties (Details) - Schedule of Salaries and Benefits to Interested and Related Parties - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Dec. 31, 2021

Schedule Of Salaries And Benefits To Interested And Related Parties Abstract

^[1],[2]

$ 2,355

$ 832

[1]	Key management personnel.
[2]	Relates to the cost of employment of Dr. Zigmund Bluvband, formerly the Chairman of the Company’s Board. Dr. Zigmund no longer works at the Company since April 30, 2022.

Label

Element

Value

Outstanding Debt Period

hubc_OutstandingDebtPeriod

120 years

Other Accounts Receivable

hubc_OtherAccountsReceivable

$ 2,703,000

Other Accounts Receivable

hubc_OtherAccountsReceivable

$ 614,000

Warrant Exercise Price

hubc_WarrantExercisePrice

$ 11.5

Warrant Exercise Price

hubc_WarrantExercisePrice

$ 0.8

Schedule Of Information On Leases Table Text Block

hubc_ScheduleOfInformationOnLeasesTableTextBlock

Information on leases:

	Year ended December 31,
	2023		2022		2021
	USD in thousands

Interest expense on lease liabilities		181		258		210
Total cash outflow for leases		1,711		2,240		1,175

Non Cash Assets Acquisition

hubc_NonCashAssetsAcquisition

$ (4,796,000)

Non Cash Assets Acquisition

hubc_NonCashAssetsAcquisition

Non Cash Assets Acquisition

hubc_NonCashAssetsAcquisition

Issued Per Share

hubc_IssuedPerShare

$ 10

Allocated Share

hubc_AllocatedShare

20,000

Allocated Share

hubc_AllocatedShare

25,000

Allocated Share

hubc_AllocatedShare

174

Adjustment For Increase Decrease In Changes In Asset And Liability Items

hubc_AdjustmentForIncreaseDecreaseInChangesInAssetAndLiabilityItems

$ 14,044,000

Adjustment For Increase Decrease In Changes In Asset And Liability Items

hubc_AdjustmentForIncreaseDecreaseInChangesInAssetAndLiabilityItems

16,481,000

Adjustment For Increase Decrease In Changes In Asset And Liability Items

hubc_AdjustmentForIncreaseDecreaseInChangesInAssetAndLiabilityItems

$ 632,000

Converted Warrants Per Share

hubc_ConvertedWarrantsPerShare

$ 0.899

Conversion Of Stock

hubc_ConversionOfStock

$ 0.9

Received Amount

hubc_ReceivedAmount

$ 4,000,000

Received Amount

hubc_ReceivedAmount

$ 50,000,000

Warrant Issued And Outstanding Of Ordinary Shares

hubc_WarrantIssuedAndOutstandingOfOrdinaryShares

$ 0.899

Ordinary Shares

hubc_OrdinaryShares

1,278,666

Repayment Of Lease Liabilities

hubc_RepaymentOfLeaseLiabilities

$ 1,711,000

Repayment Of Lease Liabilities

hubc_RepaymentOfLeaseLiabilities

2,065,000

Repayment Of Lease Liabilities

hubc_RepaymentOfLeaseLiabilities

1,079,000

Employee Benefit Assets And Liabilities

hubc_EmployeeBenefitAssetsAndLiabilities

97,000

Employee Benefit Assets And Liabilities

hubc_EmployeeBenefitAssetsAndLiabilities

121,000

Employee Benefit Assets And Liabilities

hubc_EmployeeBenefitAssetsAndLiabilities

Schedule Of Rightofuse Assets Net Table Text Block

hubc_ScheduleOfRightofuseAssetsNetTableTextBlock

Disclosures in respect of right-of-use assets, net:

	Office lease			Motor Vehicles			Total
	USD in thousands
Cost:

Balance as of January 1, 2023		7,231			1,794			9,025
Additions during the year:
New leases		-			643			643
Terminated lease		(2,961	)		(80	)		(3,041	)
Classification		-			71			71
Adjustments arising from indexation		137			-			137
Other		(19	)		-			(19	)
Adjustments arising from translating financial statements from functional currency to presentation currency		(264	)		(10	)		(274	)

Balance as of December 31, 2023		4,124			2,418			6,542

Accumulated depreciation:

Balance as of January 1, 2023		1,528			990			2,518
Additions during the year:
Depreciation in the year		1,033			530			1,563
Adjustments arising from translating financial statements from functional currency to presentation currency		(28	)		(20	)		(49	)

Balance as of December 31, 2023		2,533			1,500			4,032

Depreciated cost as of December 31, 2023		1,591			918			2,510

	Office lease			Motor Vehicles			Total
	USD in thousands
Cost:

Balance as of January 1, 2022		7,510			1,262			8,772
Additions during the year:
New leases		243			711			954
Adjustments arising from indexation		379			-			379
Adjustments arising from translating financial statements from functional currency to presentation currency		(901	)		(179	)		(1,080	)

Balance as of December 31, 2022		7,231			1,794			9,025

Accumulated depreciation:

Balance as of January 1, 2022		168			369			537
Additions during the year:
Depreciation in the year		1,445			695			2,140
Adjustments arising from translating financial statements from functional currency to presentation currency		(85	)		(74	)		(159	)

Balance as of December 31, 2022		1,528			990			2,518

Depreciated cost as of December 31, 2022		5,703			804			6,507

warrant Issued

hubc_warrantIssued

53,599

warrant Issued

hubc_warrantIssued

1,550,784

Disclosure Of Salaries And Benefits To Interested And Related Partiestext Block

hubc_DisclosureOfSalariesAndBenefitsToInterestedAndRelatedPartiestextBlock

Salaries and benefits to interested and related parties:

	Year ended December 31,
	2023		2022		2021
	USD in thousands
Cost of sales, research and development expenses, sales and marketing expenses and general and administrative expenses, net:
Salary and related benefits to CEO and director employed by the Company (controlling shareholder) including cost of share-based payment (1)		132		-		-
Fees of directors not employed by the Company including cost of share-based payment (7)		566		312		289
Salary and related benefits to formerly Deputy CEO including cost of share-based payment (2)		811		3,872		1,571
Salary and related benefits to the former VP Human Resources including cost of share-based payment (4)		28		1,140		544
Salary and related benefits to formerly Chairman of the Board including cost of share-based payment (3) (6)		-		2,355		832
Salary and related benefits to formerly Deputy CEO and COO including cost of share-based payment (5) (6)		-		1,777		803
		1,537		9,456		4,039

(1)	Relates to the cost of employment of Mr. Noah Hershkovitz, director of the Company as of October 3, 2023 and CEO of the Company as of December 4, 2023.

(2)

Relates to the cost of employment of Mr. Uzi Moskowitz director and former CEO in the Company, who no longer serves as the CEO of Company since December 4, 2023. and Eyal Moshe former director and former CEO of the Company who is also controlling shareholder in the Company, excluding any misappropriates expenses. Mr. Moshe ceased his role as CEO on February 2, 2023, and his employment was terminated effective July 24, 2023 for cause in connection with these unauthorized expenses.

(3)	Relates to the cost of employment of Dr. Zigmund Bluvband, formerly the Chairman of the Company’s Board. Dr. Zigmund no longer works at the Company since April 30, 2022.

(4)	Relates to the cost of employment of Ms. Ayelet Bitan, Chief of Staff in the Company and the spouse of Mr. Eyal Moshe, a controlling shareholder in the Company, excluding any allegedly misappropriated expenses as detailed in Note 1e. Ms. Bitan resigned in February 2023.

(5)	Relates to the cost of employment of Mr. Dotan Moshe, former Deputy CEO and COO in the Company, who is also the son-in-law of Dr. Zigmund Bluvband. Mr. Dotan no longer works at the Company since May 15, 2022. In February 2023 he began consulting the Company.

(6)	Key management personnel.

(7)	Other interested and related parties.

*	The salary and related benefits amounts including the additional expenses of the extension in 2022 of the expiry date of options as detailed in note 18f.

Trading Days

hubc_TradingDays

5,000,000

Gross Proceeds

hubc_GrossProceeds

$ 50,000,000

Percentage Of Issued And Outstanding Share Capital

hubc_PercentageOfIssuedAndOutstandingShareCapital

46.52%

Warrants To Purchase Shares

hubc_WarrantsToPurchaseShares

1,604,383

Warrants

hubc_Warrants

1,278,666

Reclassification Of Deffered Ussuance Cost To Equity

hubc_ReclassificationOfDefferedUssuanceCostToEquity

$ 1,384,000

Reclassification Of Deffered Ussuance Cost To Equity

hubc_ReclassificationOfDefferedUssuanceCostToEquity

1,717,000

Reclassification Of Deffered Ussuance Cost To Equity

hubc_ReclassificationOfDefferedUssuanceCostToEquity

Extension Options Term

hubc_ExtensionOptionsTerm

5 years

Extension Options Term

hubc_ExtensionOptionsTerm

5 years

Extension Options Term

hubc_ExtensionOptionsTerm

2 years

Extension Options Term

hubc_ExtensionOptionsTerm

5 years

Percentage Of Management Fees

hubc_PercentageOfManagementFees

3.00%

Average Price Percentage

hubc_AveragePricePercentage

40.00%

Investment Amount

hubc_InvestmentAmount

$ 5,000,000

Dividend Distribution To Noncontrolling Interests

hubc_DividendDistributionToNoncontrollingInterests

369,000

Dividend Distribution To Noncontrolling Interests

hubc_DividendDistributionToNoncontrollingInterests

Dividend Distribution To Noncontrolling Interests

hubc_DividendDistributionToNoncontrollingInterests

Broker-Dealer, Bank Loan, Short-Term

srt_BankLoans

108,000

Broker-Dealer, Bank Loan, Short-Term

srt_BankLoans

4,063,000

Conversion Of Convertible Loans

hubc_ConversionOfConvertibleLoans

6,143,000

Conversion Of Convertible Loans

hubc_ConversionOfConvertibleLoans

Conversion Of Convertible Loans

hubc_ConversionOfConvertibleLoans

Employee Benefit Liabilities

hubc_EmployeeBenefitLiabilities

772,000

Employee Benefit Liabilities

hubc_EmployeeBenefitLiabilities

$ 59,000

Investment Agreement Shares

hubc_InvestmentAgreementShares

91,192

Total Comprehensive Income For The Year

hubc_TotalComprehensiveIncomeForTheYear

$ (85,594,000)

Total Comprehensive Income For The Year

hubc_TotalComprehensiveIncomeForTheYear

(11,762,000)

Total Comprehensive Income For The Year

hubc_TotalComprehensiveIncomeForTheYear

$ (87,484,000)

Percentage Of Investment Holding

hubc_PercentageOfInvestmentHolding

98.63%

Percentage Of Investment Holding

hubc_PercentageOfInvestmentHolding

46.52%

Percentage Of Investment Holding

hubc_PercentageOfInvestmentHolding

25.00%

Purchase Price

hubc_PurchasePrice

$ 70,000,000

Purchase Price

hubc_PurchasePrice

$ 21,848,000

Leases Term

hubc_LeasesTerm

2 years

Leases Term

hubc_LeasesTerm

10 years

Leases Term

hubc_LeasesTerm

3 years

Leases Term

hubc_LeasesTerm

4 years

Leases Term

hubc_LeasesTerm

3 years

Leases Term

hubc_LeasesTerm

10 years

Leases Term

hubc_LeasesTerm

12 months

Leases Term

hubc_LeasesTerm

10 years

Leases Term

hubc_LeasesTerm

2 years

Leases Term

hubc_LeasesTerm

5 years

Issuance Of Shares And Warrants